US 11191843
Multi-arm targeting anti-cancer conjugate
granted A61KA61K31/4745A61K47/60
Quick answer
US patent 11191843 (Multi-arm targeting anti-cancer conjugate) held by BrightGene Bio-Medical Technology Co., Ltd. expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BrightGene Bio-Medical Technology Co., Ltd.
- Grant date
- Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4745, A61K47/60, A61K47/64, A61K47/65